Clincosm LogoSign in Get a demo

Ribose and Sport Performance

Sponsor
Laval University (Other)
Overall Status
Completed
CT.gov ID
NCT01727479
Collaborator
Atrium Innovations (Industry)
18
Enrollment
1
Location
2
Arms
5
Duration (Months)
3.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Investigate the acute effect of ribose supplementation on performance and recovery in athletes.

Condition or Disease Intervention/Treatment Phase
  • Other: Ribose
  • Other: Placebo
 N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
18 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
The Effect of Ribose on Performance and Recovery in Athletes
Study Start Date :
Aug 1, 2012
Actual Primary Completion Date :
Jan 1, 2013
Actual Study Completion Date :
Jan 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ribose

After each of the 3km time trial (3 in total), consumption of ribose incorporated in a sports drink.

Other: Ribose
After each of the 3km time trial (3 in total), participants will be asked to drink the experimental product (or placebo) incorporated in a sports drink.
Placebo Comparator: Placebo

After each of the 3km time trial (3 in total), consumption of placebo incorporated in a sports drink.

Other: Placebo

Outcome Measures

Primary Outcome Measures

  1. Change in time to complete the third of 3 consecutive 3km time trials on bike [baseline and 1 week]

Secondary Outcome Measures

  1. Performance on the 3 consecutive 3km time trials on bike [baseline and 1 week]

    Performance measures: peak power (watts/kg), mean power (watts/kg), time to peak power (sec), total work (kJ) and maximum cadence (RPMmax)

Other Outcome Measures

  1. Fatigue perception after each of the 3 consecutive 3km time trials on bike [baseline and 1 week]

    Post-exercise fatigue perception on visual analog scale (VAS)

  2. Peak Vo2 consumption during each of the 3km time trials on bike [baseline and 1 week]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

  • Men and women

  • Training volume > 7hrs/week

  • VO2 max > 40 and 45 mg/kg/min (for women and men respectively)

  • Otherwise healthy individuals

Exclusion Criteria:

  • Pregnant or breastfeeding women

  • Individuals with endocrine disorders, hypercholesterolemia, cardiovascular diseases, gut diseases, cancer, anemia, hypoglycemia

  • Medication for lipids, diabetes, hypertension, inflammation, autoimmune diseases, mood disorders

  • Excessive alcohol consumption (more than two drinks by day for men, one for women), smoking, drug use, supplements or natural products consumption during the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Université Laval Québec Quebec Canada G1V0A6

Sponsors and Collaborators

  • Laval University
  • Atrium Innovations

Investigators

  • Principal Investigator: Benoît Lamarche, PhD, Institute on nutraceuticals and functional foods

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Laval University
ClinicalTrials.gov Identifier:
NCT01727479
Other Study ID Numbers:
  • 2012-048
  • INAF-2012-048
First Posted:
Nov 16, 2012
Last Update Posted:
Dec 5, 2016
Last Verified:
Dec 1, 2016
Keywords provided by Laval University
Peak VO2 consumption
3km time trial
fatigue perception
lactate
time to complete

Study Results

No Results Posted as of Dec 5, 2016